Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hetero Healthcare is a leading Indian pharmaceutical company specializing in the development, manufacturing, marketing, and distribution of branded generics and biosimilars. It is recognized for its strong presence in antiretroviral therapies, oncology, anti-flu medications, and other key therapeutic areas. The company has a robust R&D focus and extensive distribution across India and emerging markets. Its parent group played a major role during global health crises by supplying large quantities of oseltamivir during the swine flu outbreak and launching generic COVID antivirals such as remdesivir.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hetero Healthcare.